Army Dengue Vaccine Trial Supported by State University of New York
The United States Army Medical Research Acquisition Activity (USAMRAA) is awarding a new contract in support of an experimental dengue ...
Tag: Vaccines
Novartis Receives FDA Approval for First Cell-Culture Influenza Vaccine
The Food and Drug Administration (FDA) this week approved the use of Novartis’ Flucelvax vaccine in adults, becoming the first ...
Key Patent Awarded for Synthetic Saponin Vaccine Adjuvant
The United States Patent and Trademark Office has granted the co-founders of Adjuvance Technologies, Inc., a patent for a pioneering ...
NIH, CDC Small Business Innovation for Medical Countermeasures
An extended proposal deadline has been issued by the National Institutes of Health (NIH) and the Centers for Disease Control and ...
Naval Medical Research Center Advancing Malaria Vaccines
The Naval Medical Research Center (NMRC) Malaria Program, in pursuit of a long-term goal of developing malaria vaccines to protect ...
Surprising Find May Lead to Glanders Vaccine
Apichai Tuanyok dedicated several years to working on a bacterial pathogen in Canada, but his breakthrough occurred in Flagstaff with an ...
NIAID Issues RFI for Biodefense Dry Vaccine Development
The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Request for Information (RFI) seeking input from product ...
NIAID Awards Funding for Non-Needle Anthrax Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Pfenex, Inc., a contract to develop an alternative dry ...
BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine
Emergent Biosolutions announced today that, after completion of an inter-agency In Process Review, the Biomedical Advanced Research Development Authority (BARDA) ...
NIH Awards $1.8M to Develop Multi-Component Malaria Vaccine Solution
The National Institutes of Health (NIH) last month awarded three Phase I Small Business Innovation Research (SBIR) grants to Protein ...
iBio Expands Plant-Based Vaccine Biodefense Portfolio
iBio, Inc. this week announced issuance of a U.S. patent covering compositions of matter and methods of producing and formulating anthrax ...
HHS Announces Pandemic Preparedness Contracts to Top Pharma
The U.S. Department of Health and Human Services (HHS) has taken historic steps to support the nation’s pandemic preparedness efforts ...
Ricin Vaccine Shows Positive Phase 1B Clinical Trial Results
Soligenix last week announced the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of ...
Biodefense BAA Supports Adjuvant Development for Emerging Diseases
The National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation is renewing a Broad Agency ...
NIH, CDC Announce Small Business Innovation Research Opportunity
The National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC) are soliciting proposals from small businesses ...
DARPA Program Hits Milestone in Plant-Based Vaccines for Pandemics
In a recent milestone development under the Defense Advanced Research Project Agency (DARPA) “Blue Angel” program, researchers at Medicago Inc. ...
Using Silk Films to Ruggedize Vaccines and Antibiotics
Researchers have developed a new silk-based stabilizer that shows benefit for keeping vaccines and antibiotics stable up to temperatures of ...
Plum Island Scientists Develop New FMD Vaccine
Scientists at the Plum Island Animal Disease Center (PIADC) have developed a molecular vaccine against foot and mouth disease virus ...
Partnership to Develop Thermostable Biodefense Vaccines
The Infectious Disease Research Institute (IDRI) of Seattle, WA will be teaming up with biopharmaceutical company Soligenix to develop biodefense ...
Merck, Sanofi Pasteur Awarded Military Flu Vaccine Orders
Merck & Co., Inc., West Point, Pa., was awarded a firm-fixed-price contract with a maximum of $11,555,970 for flu vaccines ...
